Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Silvia Halim"'
Hypoxia-inducible factor (HIF) and aryl hydrocarbon receptor (AHR) are members of the bHLH-PAS family of transcription factors that underpin cellular responses to oxygen and to endogenous and exogenous ligands, respectively, and have central roles in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68de98ce1d07927fdc7325dfd7266d03
Publikováno v:
Cancer Research. 82:677-677
Hypoxia is a key feature of the solid tumour microenvironment, in which it is associated with poor prognosis and resistance to therapy. Hypoxia-inducible factor (HIF) is the central mediator of cellular responses to hypoxia and drives a transcription
Publikováno v:
Cancer Research. 82:119-119
Low levels of tissue oxygen, or intra-tumor hypoxia, is a common feature of many solid cancers in which dysregulated cell proliferation often outstrips the ability to develop new functional blood vessels. Furthermore, hypoxia pathways may also be act
Publikováno v:
British Journal of Cancer
Background Human cancers can be classified based on gene signatures quantifying the degree of cell proliferation and tissue remodelling (PR). However, the specific factors that drive the increased tissue remodelling in tumours are not fully understoo
Autor:
Johan Lindberg, Robert Karlsson, Tom Whitington, Ping Gao, Daniel Klevebring, Henrik Grönberg, Silvia Halim, David E. Neal, Anne Y. Warren, Mark J Dunning, Lars Egevad, Fredrik Wiklund, Ilaria Svezia, Wei Song, Gong-Hong Wei, Yuehong Yang, Alastair D. Lamb, Ian G. Mills, Helen Ross-Adams
Publikováno v:
Nature Genetics. 48:387-397
Thomas Whitington and colleagues present a detailed characterization of gene regulatory mechanisms underlying prostate cancer susceptibility. Their analysis highlights key mechanisms altered by disease-associated SNPs, including widespread disruption
Autor:
Leandro M. Colli, Rafik Salama, Silvia Halim, Véronique N. Lafleur, David R. Mole, Stephen J. Chanock, Virginia Schmid, Ran Li, Peter J. Ratcliffe, Olivia Lombardi
Publikováno v:
Cancer Research. 80:3436-3436
The purpose of this study was to determine whether specific components of the HIF-transcriptional pathway are under selective pressure during the development of cancer. Induction of HIF is a common feature of most cancers that frequently results from
Autor:
Theodorus van der Kwast, Xianyue Meng, Rosalind A. Eeles, David E. Neal, Jenna Sykes, Silvia Halim, Lauren C. Chong, Igor Jurisica, Lucia L. Lam, Alastair D. Lamb, Elai Davicioni, Denise Y.F. Mak, Wan L. Lam, Kenneth C. Chu, Helen Ross-Adams, Michael Milosevic, Nicholas Erho, John Thoms, Anne Y. Warren, Alejandro Berlin, Chad A. Malloff, Mark J Dunning, Emilie Lalonde, Honglei Xie, Melania Pintilie, CQ Yao, Cherry Have, Dorota H. Sendorek, Nicholas J. Harding, Robert G. Bristow, Michael Fraser, Christine P'ng, Jeremy A. Squire, Alan Dal Pra, Colin Cooper, Colin Collins, Michal R. Grzadkowski, Varune Rohan Ramnarine, Nathalie C. Moon, Gaetano Zafarana, Adrian Ishkanian, Paul C. Boutros
Publikováno v:
The Lancet Oncology. 15(13):1521-1532
Summary Background Clinical prognostic groupings for localised prostate cancers are imprecise, with 30–50% of patients recurring after image-guided radiotherapy or radical prostatectomy. We aimed to test combined genomic and microenvironmental indi
Autor:
Ian G. Mills, C M Massie, Silvia Halim, Jonathan Kay, Antonio Ramos-Montoya, Cyrus Cooper, Sarah L. Vowler, Vincent J. Gnanapragasam, Jeremy Clark, Mark J Dunning, N L Sharma, Rachel Hurst, Hayley C. Whitaker, N C Shah, Helen Ross-Adams, Andy G. Lynch, Rory Stark, Henrik Grönberg, A Y Warren, David E. Neal, Lars Egevad, Alastair D. Lamb, Johan Lindberg, Roslin Russell
Publikováno v:
EBioMedicine
EBioMedicine, Vol 17, Iss C, p 238 (2017)
EBioMedicine, Vol 17, Iss C, p 238 (2017)
Background Understanding the heterogeneous genotypes and phenotypes of prostate cancer is fundamental to improving the way we treat this disease. As yet, there are no validated descriptions of prostate cancer subgroups derived from integrated genomic
Autor:
Mohammad Asim, Silvia Halim, Martin Mørck Mortensen, Hayley C. Whitaker, Adele Murrell, Anne Y. Warren, Simon A. Gayther, Alastair D. Lamb, Ian G. Mills, Jonathan D. Kay, Stephen J. Ball, Sebastian M. Armasu, Antonio Ramos-Montoya, Karina Dalsgaard Sørensen, Siri H. Strand, Claire M. Wells, Michael Borre, Kathryn Woodfine, Melissa C. Larson, Charles E. Massie, Kate Lawrenson, Ellen L. Goode, David E. Neal, Roslin Russell, Torben F. Ørntoft, Brooke L. Fridley, John R. W. Masters, Helen Ross-Adams
Publikováno v:
Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S H, Ørntoft, T F, Larson, M, Armasu, S, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', Oncotarget, vol. 7, no. 46, pp. 74734-74746 . https://doi.org/10.18632/oncotarget.12543
Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S H, Ørntoft, T F, Larson, M, Armasu, S, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', Oncotarget . https://doi.org/10.18632/oncotarget.12543
Oncotarget
Ross-Adams, H, Ball, S J, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S, Ørntoft, T F, Larson, M C, Armasu, S M, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J R, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', OncoTarget, vol. 7, no. 46, pp. 74734-74746 . https://doi.org/10.18632/oncotarget.12543
Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S H, Ørntoft, T F, Larson, M, Armasu, S, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', Oncotarget . https://doi.org/10.18632/oncotarget.12543
Oncotarget
Ross-Adams, H, Ball, S J, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S, Ørntoft, T F, Larson, M C, Armasu, S M, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J R, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', OncoTarget, vol. 7, no. 46, pp. 74734-74746 . https://doi.org/10.18632/oncotarget.12543
Two independent regions within HNF1B are consistently identified in prostate and ovarian cancer genome-wide association studies (GWAS); their functional roles are unclear. We link prostate cancer (PC) risk SNPs rs11649743 and rs3760511 with elevated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1087fbe6b7f09cc62ecb72e3ad4e3d33
https://kclpure.kcl.ac.uk/en/publications/9de950f5-0783-47e3-8734-2c4c386c1c49
https://kclpure.kcl.ac.uk/en/publications/9de950f5-0783-47e3-8734-2c4c386c1c49
Autor:
Mauro A. A. Castro, Thomas M. Campbell, Kerstin B. Meyer, Michael N. C. Fletcher, Ines de Santiago, Bruce A.J. Ponder, Radhika Prathalingam, Silvia Halim
Publikováno v:
Carcinogenesis
Summary The fibroblast growth factor receptor 2 (FGFR2) locus is the ‘top hit’ in genome-wide association studies for breast cancer. Here, we examine the effect of FGFR2 signalling on transcriptional networks in breast cancer and propose a mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::503b1924af2b81f1f0014d81657a1a4f